A financial statement detailing investments in various biotech companies as of April 2, 2014, including quantities, trade dates, current prices, unit costs, market values, total costs, and unrealized gains/losses.
documents/vol00010-efta01461587-pdf.pdf
{"document_date":"2014-04-02","document_type":"tabular","document_subtype":"financial statement","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"],"reference_numbers":["DB-SDNY-0123728","SDNY_GM_00269912","EFTA01461587"]}